51 results
Page 2 of 3
8-K
EX-99.1
3oaf4b8u 20
3 Nov 22
Regulation FD Disclosure
9:05am
8-K
EX-99.1
sl7fv95b gknqvalf7
10 Aug 22
Adicet Reports Second Quarter 2022 Financial Results and Provides Business Updates
12:00am
8-K
EX-99.1
n0umrgqnvev
6 Jun 22
Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting
4:01pm
8-K
4gdl nzymistcb
6 Jun 22
Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting
4:01pm
8-K
EX-99.1
kyzxppxba1a0zcq an0
26 May 22
Regulation FD Disclosure
5:10pm
8-K
EX-99.1
wn2 is0d337j3b84b6w6
12 May 22
Adicet Reports First Quarter 2022 Financial Results and Provides Business Updates
4:18pm
8-K
EX-99.1
0hzin2ak4da
5 May 22
Regulation FD Disclosure
7:03am
8-K
EX-99.1
aze6sbm7cjx1
15 Mar 22
Adicet Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress
4:10pm
8-K
gbhw3
12 Nov 21
Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting
7:18am
8-K
EX-99.1
sj3w91z5c9
12 Nov 21
Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting
7:18am
8-K
EX-99.1
2wie0p 8omgx5
10 Nov 21
Adicet Reports Third Quarter 2021 Financial Results and Provides Business Updates
4:12pm
8-K
EX-99.3
uhw39ne
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.4
2yb1c9n
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
424B3
1t1uyxxkye4rxxnwxl
21 Aug 20
Prospectus supplement
8:36am